Medscape: AI’s Drug Revolution, Part 3: Making Proteins From Scratch
Sep 19, 2024
Absci Founder and CEO Sean McClain recently sat down with Medscape’s Sarah Amandolare to discuss the impact de novo AI protein design could have on the drug discovery process. Check out the full article here: https://www.medscape.com/viewarticle/ais-drug-revolution-part-3-making-proteins-scratch-2024a1000gim